• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.69% Nasdaq Up 2.12%

    Becton, Dickinson and Company (BDX)

    -NYSE
    136.80 2.76(2.06%) Dec 17, 4:02PM EST
    Add to Portfolio
    Prev Close:134.04
    Open:135.05
    Bid:129.16 x 100
    Ask:146.42 x 100
    1y Target Est:145.17
    Beta:1.11
    Earnings Date:Feb 2 - Feb 6 (Est.)
    Day's Range:134.48 - 137.10
    52wk Range:105.21 - 142.56
    Volume:1,617,299
    Avg Vol (3m):1,603,040
    Market Cap:26.26B
    P/E (ttm):22.84
    EPS (ttm):5.99
    Div & Yield:2.40 (1.80%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BDX

    Comparison

    Symbol% ChgMkt Cap
    BDXUp 2.06%26.26B
    ABT66.65B
    BAX39.17B
    COV45.85B

    Key Statistics

    Forward P/E (1 yr):18.79
    P/S (ttm):3.05
    Ex-Dividend Date:08-Dec-14

    Analysts

    Annual EPS Est (Sep-15) :6.80
    Quarterly EPS Est (Dec-14) :1.45
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):2.78

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback